Genmab — Oktober 2019
-
Jeg syntes det er sjældent, at der er noget revolutionerende i offentliggørelsen af abstracstts - men det er måske også derfor, at vi ser et run-up til ASH, fordi investorerne agerer i mørke…
-
Den hyppigste bevægelse er stigning op til at hurtig nedstigning efterfølgende
-
Det er vel ikke urealistisk at 950 nås ultimo 19 samlet, måske endda 1000. Så må vi alt andet lige være nærmere 5bn$ for 2020 end 4bn$. Med en 10% stigning kvartallet næste år endda nærmere 6 end 5. Så analytikerne kan godt finde deres kugleramme frem.
-
I guess much depends on the schedule for SC. Unfortunately it does not look like it gets PR, or is that too early to say anything about?
-
I dont agree in your 4,3 prediction its too conservative for my taste, are you working in bank?:-) I think they will guide 4.5 and correct it in dec. to 4.8 incl. discounts. Remember chairproblem, more maintenance patient and not 10.000 in clinical trials anymore or?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind